Penumbra Inc (PEN) Executive Compensation
Penumbra Inc (PEN) is a publicly traded company on the NYSE, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PEN
CIK: 1321732
Exchange: NYSE
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMikayel Nazloyan
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | FORM 4 | 0002086163-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0002086163-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | FORM 4 | 0002086163-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000312069-26-000213 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001321732-26-000037 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001321732-26-000036 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001321732-26-000030 | View SEC Doc Filr Page |
| SD | 2026-05-29 | — | SD | 0001321732-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | FORM 4 | 0001651323-26-000002 | View SEC Doc Filr Page |
| 425 | 2026-05-07 | — | 425 | 0001321732-26-000025 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-06 | 8-K | 0001321732-26-000024 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001321732-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001321732-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-30 | — | SCHEDULE 13G Filing | 0002100119-26-000881 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001140361-26-017841 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFA14A | 0001321732-26-000012 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-18 | DEF 14A | 0001321732-26-000010 | View SEC Doc Filr Page |
| 425 | 2026-04-23 | — | FORM 425 | 0000950103-26-006105 | View SEC Doc Filr Page |
| 425 | 2026-04-22 | — | 425 | 0001104659-26-046912 | View SEC Doc Filr Page |
| 425 | 2026-04-17 | — | FORM 425 | 0000950103-26-005882 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2026-04-02 | FORM 4 | 0001375889-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-04-02 | — | 144 Filing | 0001959173-26-002756 | View SEC Doc Filr Page |
| DEFM14A | 2026-04-01 | — | DEFM14A | 0001140361-26-012785 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0000102909-26-002089 | View SEC Doc Filr Page |
| 4 | 2026-03-17 | 2026-03-15 | FORM 4 | 0002086163-26-000006 | View SEC Doc Filr Page |